Show simple item record

dc.contributor.authorMoore, Shelleyes_ES
dc.contributor.authorJaime, Lazara K. Montanees_ES
dc.contributor.authorMaharajh, Haries_ES
dc.contributor.authorRamtahal, Indares_ES
dc.contributor.authorReid, Sandraes_ES
dc.contributor.authorRamsewak, Feroza Sircares_ES
dc.contributor.authorMaharaj, Malaes_ES
dc.date.accessioned2015-08-25T14:53:36Z
dc.date.available2015-08-25T14:53:36Z
dc.date.issued2002es_ES
dc.identifier.citationMoore, Shelley,Jaime, Lazara K. Montane,Maharajh, Hari,Ramtahal, Indar,Reid, Sandra,Ramsewak, Feroza Sircar,Maharaj, Mala (2002) The prescribing of psychotropic drugs in mental health services in Trinidad. Rev Panam Salud Publica;12(3) 207-214,sept. 2002. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002000900010&lng=en&nrm=iso&tlng=enes_ES
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002000900010&lng=en&nrm=iso&tlng=enes_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/8518
dc.format.extenttabes_ES
dc.relation.ispartofseriesRev Panam Salud Publica;12(3),sept. 2002es_ES
dc.subjectTranstornos Mentaispt_BR
dc.subjectPrescrições de Medicamentospt_BR
dc.subjectPsicotrópicoses_ES
dc.subjectAntidepressivoses_ES
dc.subjectEstudos Transversaispt_BR
dc.subjectUso de Medicamentoses_ES
dc.subjectServiços de Saúde Mentalpt_BR
dc.subjectPacientes Ambulatoriaises_ES
dc.subjectFatores Socioeconômicospt_BR
dc.subjectTrinidad e Tobagoes_ES
dc.titleThe prescribing of psychotropic drugs in mental health services in Trinidades_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.description.notesObjective. To describe, analyze, and interpret patterns of psychotropic drug prescribing in new psychiatric patients attending psychiatric outpatient clinics in the Caribbean island of Trinidad. Design and Methods. This was a cross-sectional study of psychotropic drug prescribing by psychiatrists for 132 new psychiatric outpatients who were seen at the outpatient clinics surveyed and who were entering the mental health system during the period of research, November 1998 through February 1999. Results. A single patient could be prescribed more than one psychotropic drug. Antidepressant drugs were the class of psychotropic drugs most prescribed (79 of 132 patients, 59.8 percent), followed by antipsychotic drugs (67 of 132 patients, 50.8 percent). Tricyclic antidepressants (TCAs) were the antidepressants most prescribed (58 of the 79 patients), mainly amitriptyline (53 of the 58). Fluoxetine was the only selective serotonin reuptake inhibitor (SSRI) prescribed (21 of the 79 patients prescribed antidepressants). Of the 67 patients receiving antipsychotic drugs, phenothiazines accounted for 41 of those 67, including trifluoperazine (14 of the 41) and thioridazine (13 of the 41). The individual antipsychotic most prescribed was sulpiride (21 of the 67 patients). Anticholinergic drugs were prescribed to 20 of the 132 patients (15.1 percent). Eighty-three of the patients were prescribed more than one drug concomitantly (either more than one psychotropic or a combination of psychotropic(s) and nonpsychotropic(s)). Prescription by ethnicity, age, and gender coincided with the morbidity rates encountered in these patients. The prescribing of SSRIs to persons of African or East Indian ethnicity was significantly lower than it was for persons of mixed heritage. Conclusions. The prescription patterns of psychotropic drugs in Trinidad revealed the psychiatrists' preferences for traditional psychotropic drugs, the moderate use of anticholinergic drugs, and polypharmacy in some cases, with probable predisposition to adverse drug reactions. Given our results and based on the evaluation of individual patients, consideration should be given to a broader use of the newer antidepressants (SSRIs) and antipsychotics. Unless justified, polypharmacy should be avoided (AU)en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record